Qiagen N.V.
QGEN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,978 | $1,965 | $2,142 | $2,252 |
| % Growth | 0.7% | -8.2% | -4.9% | – |
| Cost of Goods Sold | $1,011 | $732 | $757 | $801 |
| Gross Profit | $967 | $1,234 | $1,385 | $1,451 |
| % Margin | 48.9% | 62.8% | 64.7% | 64.4% |
| R&D Expenses | $193 | $199 | $190 | $190 |
| G&A Expenses | $113 | $119 | $130 | $128 |
| SG&A Expenses | $564 | $579 | $604 | $584 |
| Sales & Mktg Exp. | $451 | $460 | $474 | $456 |
| Other Operating Expenses | $112 | $46 | $59 | $46 |
| Operating Expenses | $870 | $824 | $853 | $821 |
| Operating Income | $98 | $410 | $531 | $630 |
| % Margin | 4.9% | 20.9% | 24.8% | 28% |
| Other Income/Exp. Net | $23 | $20 | -$19 | -$4 |
| Pre-Tax Income | $121 | $430 | $513 | $626 |
| Tax Expense | $38 | $89 | $89 | $113 |
| Net Income | $84 | $341 | $423 | $513 |
| % Margin | 4.2% | 17.4% | 19.8% | 22.8% |
| EPS | 0.39 | 1.54 | 1.92 | 2.32 |
| % Growth | -74.7% | -19.8% | -17.2% | – |
| EPS Diluted | 0.38 | 1.57 | 1.9 | 2.28 |
| Weighted Avg Shares Out | 216 | 217 | 221 | 221 |
| Weighted Avg Shares Out Dil | 218 | 217 | 223 | 225 |
| Supplemental Information | – | – | – | – |
| Interest Income | $68 | $79 | $33 | $10 |
| Interest Expense | $44 | $53 | $58 | $54 |
| Depreciation & Amortization | $203 | $205 | $208 | $215 |
| EBITDA | $368 | $689 | $779 | $895 |
| % Margin | 18.6% | 35% | 36.4% | 39.8% |